Reported May 30, 2018 · Terminated
Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Mylan Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Pharmaceuticals Inc. · 781 Chestnut Ridge Rd · Morgantown, WV · 26505-2730
Is this the product you have?
Loxapine CapsulesUSP 50 mgRx Only100-count bottlesNDC 0378-7050-01
- Lot codes and dates
- NDC 0378-7050-01 Lot Numbers
3079386Exp. 10/31/18 3079387Exp. 10/31/18 3079388Exp. 10/31/18 3083762Exp. 3/31/19 3083763Exp. 3/31/19 3083764Exp. 3/31/19 3083765Exp. 3/31/19 3083766Exp. 3/31/19 3083767Exp. 3/31/19
- NDC 0378-7050-01 Lot Numbers
- Amount recalled
- 11,650 bottles
This recall covers 5 products
The agency filed one notice per product. You are reading one of them; the other 4 are below.
Where it was sold
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.